MADRIGAL PHARMACEU revenue breakdown overview

MADRIGAL PHARMACEU revenue for the last year amounted to 163.60 M CHF, the most of which — 163.60 M CHF — came from its highest performing source at the moment, Novel Therapeutics, the year earlier bringing 134.56 k CHF. The greatest contribution to the revenue figure was made by United States — last year it brought MADRIGAL PHARMACEU 163.60 M CHF, and the year before that — 134.56 k CHF.